These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38056487

  • 1. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
    Chao CH, Wu CY, Chou FL, Chen YJ.
    Clin Exp Dermatol; 2024 Apr 23; 49(5):459-465. PubMed ID: 38056487
    [Abstract] [Full Text] [Related]

  • 2. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
    Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ.
    Photodermatol Photoimmunol Photomed; 2019 May 23; 35(3):164-171. PubMed ID: 30536640
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
    Asawanonda P, Nateetongrungsak Y.
    J Am Acad Dermatol; 2006 Jun 23; 54(6):1013-8. PubMed ID: 16713455
    [Abstract] [Full Text] [Related]

  • 4. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC, Jeanmougin M.
    Ann Dermatol Venereol; 2010 Jan 23; 137(1):21-31. PubMed ID: 20110064
    [Abstract] [Full Text] [Related]

  • 5. TWEAK levels in psoriatic patients treated with narrowband ultraviolet B and methotrexate.
    Hegazy EM, El Taieb MA, Ibrahim HM, Rageh EM, Ahmed NM, Ibrahim AK, Younis AM, Ali MA.
    J Cosmet Dermatol; 2024 May 23; 23(5):1905-1911. PubMed ID: 38299446
    [Abstract] [Full Text] [Related]

  • 6. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
    Mehta D, Lim HW.
    Am J Clin Dermatol; 2016 Apr 23; 17(2):125-33. PubMed ID: 26872953
    [Abstract] [Full Text] [Related]

  • 7. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
    Chia BKY, Yew YW, Zhao X, Chong WS, Thng TGS.
    Photodermatol Photoimmunol Photomed; 2023 Jul 23; 39(4):343-350. PubMed ID: 36345565
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis.
    Ara S, Mowla MR, Alam M, Khan I.
    Dermatol Ther; 2020 Jul 23; 33(4):e13486. PubMed ID: 32356586
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis.
    Al-Hamamy HR, Al-Mashhadani SA, Mustafa IN.
    Int J Dermatol; 2014 Dec 23; 53(12):1531-5. PubMed ID: 24738793
    [Abstract] [Full Text] [Related]

  • 10. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
    Karaosmanoglu N, Ozdemir Cetinkaya P, Kutlu O, Karaaslan E, Imren IG, Kiratli Nalbant E, Eksioglu M.
    Arch Dermatol Res; 2020 May 23; 312(4):249-253. PubMed ID: 31729594
    [Abstract] [Full Text] [Related]

  • 11. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
    Mimouni I, Shulman J, Unes AA, Pavlovsky L, Pavlotsky F.
    Photodermatol Photoimmunol Photomed; 2024 Jan 23; 40(1):e12936. PubMed ID: 38059681
    [Abstract] [Full Text] [Related]

  • 12. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May 23; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 13. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
    Ontario Health (Quality) .
    Ont Health Technol Assess Ser; 2020 May 23; 20(12):1-134. PubMed ID: 33240453
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
    Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B.
    Br J Dermatol; 2013 Jul 23; 169(1):130-6. PubMed ID: 23834117
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis.
    Soliman A, Nofal E, Nofal A, El Desouky F, Asal M.
    J Dermatolog Treat; 2015 Jul 23; 26(6):528-34. PubMed ID: 25909368
    [Abstract] [Full Text] [Related]

  • 19. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis.
    Amornpinyokeit N, Asawanonda P.
    Photodermatol Photoimmunol Photomed; 2006 Dec 23; 22(6):285-9. PubMed ID: 17100735
    [Abstract] [Full Text] [Related]

  • 20. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
    Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, Bechara FG, Altmeyer P, Kreuter A.
    Br J Dermatol; 2011 Jun 23; 164(6):1383-6. PubMed ID: 21466532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.